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The Armc10/SVH gene: genome context, regulation of
mitochondrial dynamics and protection against
Ab-induced mitochondrial fragmentation
R Serrat1,2,7, S Mirra1,2,7, J Figueiro-Silva2,3, E Navas-Pe´rez4, M Quevedo1,2, G Lo´pez-Dome´nech1,2, P Podlesniy2,3, F Ulloa1,2,
J Garcia-Ferna`ndez4, R Trullas2,3 and E Soriano*,1,2,5,6
Mitochondrial function and dynamics are essential for neurotransmission, neural function and neuronal viability. Recently, we
showed that the eutherian-specific Armcx gene cluster (Armcx1–6 genes), located in the X chromosome, encodes for a new
family of proteins that localise to mitochondria, regulating mitochondrial trafficking. The Armcx gene cluster evolved by
retrotransposition of the Armc10 gene mRNA, which is present in all vertebrates and is considered to be the ancestor gene. Here
we investigate the genomic organisation, mitochondrial functions and putative neuroprotective role of the Armc10 ancestor
gene. The genomic context of the Armc10 locus shows considerable syntenic conservation among vertebrates, and sequence
comparisons and CHIP-data suggest the presence of at least three conserved enhancers. We also show that the Armc10 protein
localises to mitochondria and that it is highly expressed in the brain. Furthermore, we show that Armc10 levels regulate
mitochondrial trafficking in neurons, but not mitochondrial aggregation, by controlling the number of moving mitochondria. We
further demonstrate that the Armc10 protein interacts with the KIF5/Miro1-2/Trak2 trafficking complex. Finally, we show that
overexpression of Armc10 in neurons prevents Ab-induced mitochondrial fission and neuronal death. Our data suggest both
conserved and differential roles of the Armc10/Armcx gene family in regulating mitochondrial dynamics in neurons, and
underscore a protective effect of the Armc10 gene against Ab-induced toxicity. Overall, our findings support a further degree of
regulation of mitochondrial dynamics in the brain of more evolved mammals.
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Mitochondria are essential organelles for many biological
processes, including respiration, energy production and cell
viability. Owing to the length of neuronal processes (axons
and dendrites) and the function of mitochondria in neuro-
transmission, calcium buffering and neural integration, the
correct trafficking and distribution of these organelles is
crucial for neuronal function.1,2 Mitochondrial trafficking in
neurons is mediated by kinesin and dynein motors and by
several GTPases and adaptor proteins, including Miro1-2,
Trak2 and mitofusins.3–7 In fact, impaired distribution and
function of mitochondria and mutations in mitochondrial-
related motors and proteins have been found to be implicated
in numerous neurodegenerative diseases, including Parkinson,
Alzheimer and Huntington diseases, as well as in rare disorders
such as Charcot Marie-Tooth disease.2,8–10
In a previous study, we provided evidence that proteins
encoded by the eutherian-specific Armcx gene cluster in
the X chromosome (Armcx1-6, Armadillo repeat containing
X-linked) localise to mitochondria.11 Furthermore, our study
demonstrated that at least onemember of this family, Armcx3,
regulates mitochondrial dynamics in neurons and interacts
with the kinesin/Miro/Trak2 protein complex responsible for
mitochondrial trafficking.12–14 Interestingly, this interaction is
Ca2þ -dependent and Armcx3 was found to control mitochon-
drial aggregation, dynamics and trafficking in neurons.11 As
the Armcx gene cluster is highly expressed in the brain and is
specific to eutherianmammals, the findings of the above study
indicated a further degree of molecular complexity and
regulation of mitochondrial dynamics events, specifically in
the brains of eutherians – the most evolved mammals.
The Armcx gene cluster evolved by retrotransposition of an
Armc10 mRNA. Thus, the Armc10/SVH gene is present in a
single copy in all the vertebrate genomes analysed, including
eutherian mammals, and it represents the closest phyloge-
netic relative to the Armcx gene cluster. Phylogenetic
analyses have identified the Armc10 gene as being the sister
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group to all Armcx genes.11 Here, we show that the Armc10
locus resides in a large syntenic region conserved among
vertebrates and contains at least three conserved enhancers;
we also demonstrate that the Armc10/SVH protein is highly
expressed in developing and adult neurons, where it localises
to nuclei and mitochondria. Furthermore, we show that the
Armc10/SVH protein regulates mitochondrial trafficking,
interacting with the kinesin/Miro/Trak2 complex, and that
overexpression of Armc10 prevents Ab-induced mitochon-
drial fragmentation. Our data indicate a conserved role of the
Armc10/Armcx gene family in the regulation of mitochondrial
dynamics and transport in neurons and suggest a protective
role of the Armc10/SVH protein against Ab-induced toxicity.
Results
Genome context and regulation conservation in the
Armc10 locus. To analyse conservation and changes in the
genomic context of the Armc10 locus in vertebrates, we
studied the synteny of the surrounding genes in selected
species, looking for the conservation of five genes upstream
and downstream of Armc10 (Figure 1). Synteny was found to
be well conserved in all tetrapods analysed. The only
exception was found in the human genome, which did not
show conservation of the two most upstream genes.
Following the teleost-specific genome duplication event,
zebrafish only possesses single cognates of Armc10 and
surrounding genes, resulting in partial conservation of
synteny, scrambled in chromosomes 4 and 25.
Next, the conservation of non-coding regions in the
genomic context of Armc10 was analysed using VISTA,
and the results were compared with available information on
the histone code and transcription factor ChIP-Seq from the
ENCODE Project (Figure 2). Taking the human genome as
reference, no sequence conservation was found beyond
mammals. However, a significant peak with enhancer
histone marks was observed in one of the introns of the
bystander gene FBXL13, as well as two weak peaks
conserved in both placental mammals and marsupials, one
located in an intron of Armc10 and another in an intron of
the NAPEPLD gene (Figure 2). Conserved regions with the
enhancer histone mark, H3K4me1, but without a signal for the
promoter histone mark, H3K4me3, may be considered as
putative enhancers.15
The genome context of the Armc10 gene is clearly in
contrast to the X chromosome Armcx 1–6 cluster,11 which
originated after a retrotransposition event at the base of the
eutherian tree; hence, the Armcx cluster does not show any
synteny relationship, nor does it share any regulatory
sequences, with the Armc10 genome context. Furthermore,
the transcription units are evidently unrelated: the mouse
Armc10 protein sequence is encoded by seven exons
localised in chromosome 7q11.22,16 whereas the Armcx
proteins are all encoded in a single exon.
Neuronal expression and mitochondrial localisation of
the Armc10/SVH protein. The available RNA-seq data
show that the Armc10 gene is expressed in several tissues
– but predominantly in the brain – in zebrafish, Xenopus,
chicken, mouse and humans (Figure 3a). However, these
data do not take alternative spliced isoforms into account,
and it has been proposed that up to six isoforms arise from
alternative splicing of the Armc10 gene (Figure 3b). Of these,
four have been detected in human hepatocarcinoma cells
(Armc10 A–D).16 The Armc10 protein contains a transmem-
brane domain at the N-terminus (aa 7–29), a putative
cleavage site (aa 30–36) and a flanking basic region near
the transmembrane region (similar to that found in Tom20
and Bcl-w), which predicts putative targeting to the outer
mitochondrial membrane.17 Full-length Armc10 (A isoform)
contains up to six armadillo domains arranged in a
DUF634 domain (aa 85–337), which are partially deleted in
some isoforms. The protein also contains nuclear export
signals and several potential phosphorylation sites
(Figure 3b).
Western blot (WB) experiments revealed that an
anti-Armc10 antibody recognised up to four bands in
untransfected HEK293T cells (Figure 3c), which presumably
correspond to different Armc10 isoforms. WBs of embryonic
and adult brain lysates showed a prominent 31-kDa band,
Figure 1 Conserved gene synteny surrounding the Armc10 locus in vertebrates. Extended synteny of Armc10 is conserved in all tetrapods with the exception of humans.
In zebrafish, the synteny is lost, most probably due to the fish-specific genome duplication event and subsequent specific gene losses. Arrows indicate genes (red: Armc10,
black: syntenic genes, grey: non-syntenic genes) and direction of transcription. Dashed lines indicate large genomic regions
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which probably corresponds to the Armc10 C and/or E
isoforms. We analysed the regional and cellular patterns of
protein distribution using immunohistochemistry. Thus, the
Armc10 protein showed wide expression both at develop-
mental (E16-P5) and adult (Figure 3d–h) stages, labelling
many neuronal populations. Immunostaining was prominent
in the cerebral cortex, hippocampus, thalamus and cerebel-
lum. In most developing and adult neurons, Armc10 signals
were prominent in neuronal nuclei and fainter staining was
detected in neuronal perikarya and in the neuropil.
Figure 2 VISTA plots of the alignment of the region close to the Armc10 locus among six tetrapod species. The genomic region analysed extends 165 kb (first half in upper
panel, second half in lower panel). H3K4me3 and H3K4me1 histone marks from the ENCODE Project on seven cell lines for the region in human are shown below the VISTA
plot. Peaks (blue: exons, light blue: UTR, pink: non-coding region) indicate regions with a conservation of at least 70% and a minimum width of 100 bp. Non-coding peaks with
enhancer histone marks are highlighted in pale green
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To gain a better understanding of the subcellular distribution
of endogenous Armc10 protein, we immunostained HEK293T
cells and hippocampal primary cultures. These cells exhibited
marked co-staining of the Armc10 protein with mitochondrial
markers in both cell bodies and neurites (Figure 4a–c).
To confirm this localisation, the protein levels of Armc10 were
examined by WB after brain mitochondrial isolation; these
experiments showed a marked mitochondrial enrichment of
the Armc10 protein (Supplementary Figure 1). The above data
indicate that, as with the Armcx3 protein, Armc10 is widely
expressed in the nervous system, where it shows a mainly
bimodal localisation in mitochondria and the cell nucleus.
Armc10 protein regulates mitochondrial aggregation
and trafficking. To examine the role of the Armc10 protein
in mitochondrial dynamics, we transfected HEK293T cells
and hippocampal neurons with a GFP-tagged Armc10 cDNA.
In agreement with the above results, transfection of Armc10
yielded a preferential localisation of this protein in mitochon-
dria (Figure 4d and e). Armcx3 overexpression has been
found to lead to mitochondrial aggregation.11 To study whether
this also held true for the Armc10 protein, we analysed the
mitochondrial phenotypes induced by Armc10-GFP over-
expression. In control HEK293T cells, most transfected cells
(MitDsRed) displayed a regularly arranged mitochondrial
meshwork (as in Figure 4a and f). In contrast, up to 78% of
cells overexpressing Armc10 displayed abnormal mitochon-
drial phenotypes, whereas 29% of cells showed strong
phenotypes in which mitochondria were aggregated in a single
cluster near the cell nucleus (Figure 4e and f) and 49% of
transfected cells displayed milder degrees of mitochondrial
aggregation involving several clusters in which individual
mitochondria were still visible (Figure 4d and f).
However, overexpression of Armc10-GFP in cultured
hippocampal neurons only caused mild mitochondrial aggre-
gation, without leading to strongly aggregating phenotypes.
Thus, only 33% of transfected neurons displayed mildly
aggregating phenotypes, with small clusters of mitochondria
present in both the cell body and neurites (Figure 4g–i). The
differential aggregation of phenotypes caused by Armc10
overexpression in HEK293T cells and neurons supports the
notion of a differential regulation of mitochondrial dynamics
and aggregation in these two cell types.
To determine whether Armc10 protein levels alter
mitochondrial trafficking in neurons, we first transfected
hippocampal neurons with Armc10-GFP cDNA or with the
control vector MitDsRed. Two days later, axons from
transfected neurons were identified and recorded for
15min, and mitochondrial dynamics were quantified
using kymographs.11,12 Control neurons displayed active
mitochondrial trafficking (B30% of mitochondria) in antero-
grade and retrograde directions (Figure 5a and b). Individual
mitochondria moved at an average velocity ofB0.16–0.19mm/s
(for retrograde and anterograde transport, respectively;
Figure 5b). Overexpression of Armc10-GFP resulted in a
marked decrease in the percentages of motile mitochondria in
both anterograde and retrograde directions. In contrast, the
velocity of the mitochondria that remained motile was
unaffected by Armc10 overexpression (Figure 5b). These
results were independent of mitochondrial numbers in axons
(Supplementary Figure 2). To study the contribution of
endogenous Armc10 protein to mitochondrial transport, we
designed shRNA sequences corresponding to the C-terminal
region of Armc10 in order to knockdown all endogenous
Armc10 isoforms (Figure 5c; see also Figure 3b). In addition,
Armc10 downregulation resulted in a percentage of motile
mitochondria that was reduced by more than half in the
retrograde and anterograde directions of transport, in
comparison with control neurons transfected with a scrambled
sequence. Interestingly, the velocity of the mitochondria that
remained motile was unaffected by the levels of Armc10
protein expression (Figure 5d and e). These findings indicate
that Armc10 protein levels regulate mitochondrial trafficking in
neurons mainly by controlling the percentage of motile
mitochondria.
Armc10 protein interacts with the KHC/Miro/Trak2 com-
plex. Mitochondrial trafficking in neurons is believed to be
controlled by the kinesin 1 motor protein and by the adaptor
and Rho GTPase proteins Trak2 and Miro1-2, respectively.5–7
We thus studied whether the Armc10 protein interacts with
the kinesin/Miro/Trak2 trafficking complex. Immuno-
fluorescence analyses in transfected HEK293T cells showed
strong colocalisation of Armc10 with Miro2 and Trak2,
and partial overlapping with KIF5C (Figure 6a and
Supplementary Figure 3). Co-immunoprecipitation experi-
ments in HEK293T cells transfected with Armc10-GFP and
either Miro1-myc or Miro2-myc cDNAs revealed that Miro
proteins were detected by WB in lysates immunoprecipitated
with anti-GFP antibodies. Conversely, immunoprecipitation
with anti-myc antibodies revealed the Armc10-GFP protein.
No co-immunoprecipitation was detected when cells were
transfected with either Miro1-2-myc or Armc10-GFP DNA
alone (Figure 6b and not shown). Co-immunoprecipitation
experiments with the mitochondrial adaptor protein Trak2
also revealed co-association with the Armc10 protein
(Figure 6b). In contrast, we did not detect co-immunopreci-
pitation of the Armc10-GFP protein with KIF5C, KIF5A or
KIF5B in transfected HEK293T cells (Figure 6b and not
shown).
Figure 3 Schematic representation of Armc10 isoforms and expression of the Armc10 protein. (a) RNA-seq data showing the expression of Armc10 transcripts in different
adult human and mouse tissues. (b) Structure, domains and putative phosphorylation sites of six Armc10 (A–E) isoforms. They all have a potential N-terminal transmembrane
region and a predicted cleavage site. The C-terminal domain (DUF634) consists of up to six Arm-like tandem repeats, the distribution of which depends on the alternative
splicing pattern of the Armc10 gene (see numbers above representing exons). Stars point to putative phosphorylation sites by CK2 and PKC kinases. (c) WB showing that an
anti-Armc10 antibody recognises four Armc10 bands, presumably corresponding to isoforms (37.5, 34, 31 and 27 kDa) in HEK293T cells and one single band, corresponding
to isoforms of 31 kDa, in brain lysates from E16 and adult mice. (d–h) Coronal sections of P5 and adult mouse brain showing expression pattern of the Armc10 protein in the
cerebellum (d and e), neocortex (f and h) and the hippocampus (g). Boxed area in (h) shows nuclear localisation of the Armc10 protein in the neocortex. Ad: Adult; CA1–CA3:
hippocampal regions CA1–CA3; DG: dentate gyrus; gl: granular layer; HIP: hippocampus; II-III-IV: neocortical layers; ml: molecular layer; NC: neocortex; p: purkinje cell layer;
P5: post-natal day 5; WM: white matter. Scale bars: 100mm (d–h); 50mm (boxed area in h)
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To support these findings, we performed co-immuno-
precipitation assays with adult brain lysates (Figure 6c).
The Armc10 protein was found to interact both with Miro1
and Trak2, but not with KHC, the heavy chain of kinesin 1.
Reverse immunoprecipitation, with Trak2 and Miro1 antibo-
dies, also yielded the Armc10 protein (Figure 6c).
Overexpression of Armc10 protects against Ab-induced
neuronal death and mitochondrial fragmentation.
Dysfunction of mitochondrial dynamics is commonly
associated with neural diseases. For instance, Ab has
been reported to induce mitochondrial fragmentation
and fission, which is believed to contribute to neural
Figure 4 Armc10 colocalises with mitochondria and its overexpression alters mitochondrial distribution, thus leading to perinuclear aggregation in HEK293T cells but not in
neurons. (a–c) Confocal images showing mitochondrial colocalisation of endogenous Armc10 (green) with the mitochondrial marker MitDsRed (red) in HEK293T cells (a) and
in six DIV hippocampal neurons (b, axonal projection in c). (d–f) Overexpression of Armc10-GFP in HEK293T cells induces alterations in the distribution of mitochondria when
compared with the expression of MitDsRed control vector. These phenotypes were classified as ‘normal’, ‘mild’ and ‘aggregated’. Examples of HEK293T cells displaying mildly
(d) and strongly (e) aggregating mitochondrial phenotypes. (f) Histogram illustrating percentages of HEK293T mitochondrial phenotypes after transfection with MitDsRed or
Armc10-GFP. (g–i) Hippocampal neurons overexpressing an Armc10-GFP cDNA display normal mitochondrial phenotype (g) or a mildly aggregated phenotype (h) with small
clusters of mitochondria in cell bodies and neurites (arrows). (i) Histogram illustrating percentages of hippocampal neurons showing normal and mild phenotypes after
transfection with MitDsRed or Armc10-GFP. We counted 62–157 HEK293T cells and 35–41 neurons per condition. Data represent mean±S.E.M. of three independent
experiments. Nuclei were stained with bisbenzimide (blue). Scale bars: 10 mm (a–d); 20mm (b, c, f and g)
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dysfunction and neuronal death.18 To investigate whether
the Armc10 protein influences this process, we treated
cultured neurons overexpressing Armc10 with Ab (2 mM)
and determined mitochondrial sizes. As already described
elsewhere,19 incubation with Ab induced mitochondrial
fragmentation in hippocampal neurons, compared with
vehicle-treated neurons (Figure 7a,b and e). Armc10-
overexpressing neurons displayed slightly larger mitochondria
than control neurons. Moreover, overexpression of Armc10 in
hippocampal neurons completely abolished Ab-induced mito-
chondrial fragmentation (Figure 7d and e).
To further confirm the protective effect of Armc10 against
Ab toxicity, we also evaluated the percentage of cell death in
hippocampal cultures. The overexpression of Armc10 caused
a significant reduction (466%) in the number of dead cells
induced after Ab treatment (2mM), in comparison with control
neurons (Figure 7f). Together, these results indicate that
Armc10 protein levels not only modulate mitochondrial
dynamics under control conditions but also protect neurons
and mitochondria from insult-induced toxicity, fragmentation
and cell damage.
Discussion
The eutherian-specific Armcx gene cluster arose during
evolution by retrotransposition of an Armc10 mRNA, a gene
Figure 5 Armc10 protein levels regulate mitochondrial axonal transport in hippocampal neurons. (a) Series of three representative confocal images, taken every 30 s, of
live axons overexpressing MitDsRed or Armc10–GFP fusion protein. Representative kymographs giving the full-time acquisition periods are shown in lower panels.
(b) Graphical representation of the percentages of motile mitochondria, and the velocity and distance covered by individual mitochondria measured in kymographs for control
and overexpressing neurons. Data represent the mean±S.E.M. (c) Examples of axons co-expressing MitDsRed plus an Armc10-specific shRNAi or a control shRNAi. In the
right panel, HEK293T cells were co-transfected with an Armc10-myc expression construct and pLVTHM, containing several Armc10-specific shRNAi sequences (54–57) and a
scrambled control; cells were lysated and processed for WB with an anti-myc antibody. One Armc10-specific shRNAi sequence (57) downregulated Armc10 protein expression
and was selected to perform the silencing experiments. (d) Series of representative confocal images, taken every 30 s, of live axons overexpressing MitDsRed together with an
Armc10-specific shRNAi or a control shRNAi. Representative kymographs giving the full-time acquisition periods are shown in lower panels. (e) Graphical representation
of the percentages of motile mitochondria, and the velocity and distance covered by individual mitochondria measured in kymographs for shRNAi-control and
shRNAi-Armc10-overexpressing neurons. Data represent the mean±S.E.M. Scale bars: 10mm
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which is present in all the vertebrates surveyed.11 In a previous
study, we demonstrated that one of the members of the cluster,
the Armcx3 gene, is involved in the regulation of mitochondrial
dynamics, aggregation and trafficking in neurons. Here, we
investigated whether the Armc10 ancestor gene, from which the
entire gene cluster has evolved, is also involved in such
mitochondrial regulation. Our data show that the Armc10
protein preferentially localises to nuclei and mitochondria,
regulating mitochondrial dynamics and trafficking in neurons
through interaction with the KIF5/Miro/Trak2 complex.
Figure 6 Armc10 colocalises and interacts with Miro1-2 and Trak2 but not with KIF5C proteins. (a) HEK293T cells were transfected with Armc10-GFP and Miro2-myc,
Trak2-myc or KIF5C-myc and processed for immunocytochemistry. Note the high degree of colocalisation with Miro2 and Trak2, and partial colocalisation with KIF5C.
(b) Co-immunoprecipitation experiments in transfected HEK293T cells. Immunoprecipitation with myc antibodies revealed co-association of Miro2-myc and Trak2-myc
with Armc10-GFP protein. Reverse immunoprecipitation with GFP antibodies revealed interaction with Miro2-myc and Trak2-myc proteins. No co-association was observed with
KIF5C-myc. (c) Immunoprecipitation experiments in adult brain lysates. Immunoprecipitation with Armc10 antibodies reveals co-association with Miro1 and Trak2 but not with
KHC (upper three panels). Reverse immunoprecipitation shows interaction of Miro1 and Trak2 with Armc10 (bottom panel). Scale bar: 10 mm
Figure 7 Armc10/SHV protein protects against Ab-induced neuronal death and mitochondrial fragmentation. (a–d) Representative images from cultured hippocampal
neurons (axons) transfected with either MitDsRed (a and b) or Armc10-GFP (c and d), under control conditions or after Ab treatment. Note that Ab-induced mitochondrial
fragmentation is abolished after overexpression of Armc10. (e) Histogram showing average mitochondrial lengths under the experimental conditions used. (f) Histogram
showing the percentage of dead cells (Propidium iodide and Hoechst double-staining) in cultured hippocampal neurons in the same conditions as above and treated with Ab.
Note the reduction in cell death after Armc10 overexpression. Data represent mean±S.E.M. (*Po0.05, **Po0.01, ***Po0.001, two-way ANOVA and Bonferroni’s post hoc
test). Scale bar: 10mm
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Our analysis of the genomic locus of Armc10 shows that
deep synteny is conserved in all tetrapods analysed, with the
partial exception of human, which only shares three genes
upstream of the Armc10 locus. Our data suggest that a
translocation may have occurred in the ancestor of the
subfamily Homininae, since gorilla, chimpanzee and human
are the only sequenced primates that do not have the gene
distribution seen in the remaining tetrapods. In contrast,
zebrafish synteny around Armc10 is greatly altered in
comparison with other vertebrates, most probably due to
gene duplication degeneration after the extra round of
genome duplications at the base of the teleost lineage. In
addition, we identified three tentative enhancer sequences by
combining VISTA and histone mark analyses and searches.
The identification of conserved non-coding regions, coupled
with determination of histone marks, has been shown to
be useful tools in the search for regulatory regions,20,21
suggesting possible roles in the regulation of surrounding
genes. In the Armc10 genome context, we identified a putative
enhancer in the intronic regions of the Armc10 gene, and two
in the bystander genes FBXL13 and NAPEPLD. These must
be unique for the Armc10 gene, as the ArmcX cluster on the
X chromosome was originated by retrotransposition and
further tandem gene duplication and thus does not contain
any of the above regions.
In addition to mitochondrial regulation, several members
of the Armc10/Armcx gene family bear nuclear localisation
signals.11 Moreover, it has been reported that Armcx3
interacts with the transcription factor Sox10, thus regulating
its transcriptional activity,22 and that the Armc10-B
isoform controls transcription through interaction with
p53.23 Furthermore, Armc10/Armcx genes display up to
six armadillo domains arrayed in a DUF634 domain.11
This trait may indicate the participation of these domains in
the Wnt/b-Catenin pathway.24,25 Thus, although the
role of Armc10/Armcx genes in the nucleus is far from
being understood, it is probable that this gene cluster
encodes a new protein family that may potentially act
as a shuttle between the mitochondrial and nuclear
compartments.
Our data provide evidence that Armc10 interacts with the
Miro 1/2 and Trak2 proteins, two crucial components of the
mitochondrial trafficking complex in neurons.26,27 These
results suggest a model in which the Armc10 protein, through
interaction with the Kinesin/Miro/Trak2 complex, favours the
formation of this complex, thereby allowing the transport of
individual mitochondria. This notion is consistent with the
present knockdown experiments, which indicate that down-
regulation of endogenous Armc10 protein markedly
decreases the number of motile mitochondria. The phenotype
produced by Armc10 overexpression (also causing mitochon-
drial arrest) may be due to a dominant-negative effect of
Armc10, thus recruiting and/or deregulating several members
of the trafficking complex. This effect has also been described
for other mitochondria-targeted proteins, including Armcx3
and TDP43.11,28 These observations thus suggest that
appropriate levels of these proteins are required for normal
trafficking. However, we cannot exclude that Armc10 over-
expression interferes with mitochondrial trafficking by altering
additional unknown mechanisms.
Together with our previous findings,11 the present study
underscores that the Armc10/Armcx gene family encodes for
proteins with evolutionarily conserved functions in the regula-
tion of mitochondrial dynamics and transport. In addition, we
found that Armc10 overexpression induces mitochondrial
aggregation in HEK293T cells, but not in the hippocampal
neurons. This finding could be explained by differential levels
of Armc10 expression in the two cell types or by different
levels of expression of Armc10-interacting proteins regulating
aggregation. Of note, our previous study showed that over-
expression of the Armcx3 gene causes mitochondrial aggre-
gation in both neurons and HEK293 cells.11 It is interesting to
note that mitochondrial aggregation is believed to be closely
related to mitochondrial recycling and mitophagia,29,30
thereby suggesting a differential role of several Armc10/
Armcx members in this process.
In addition, we show here again that the Armc10 gene
may have unique features in the functional regulation of
mitochondrial dynamics. For instance, whereas dysregulation
of Armc10 protein levels (both overexpression and down-
regulation) causes marked mitochondrial arrest, we did not
find any evidence for the involvement of the Armc10 protein in
the regulation of the velocity of the few mitochondria that
remained motile under the two experimental conditions. In
contrast, the Armcx3 gene is involved in mitochondrial
transport velocity.11 This suggests that in contrast to Armcx3,
the Armc10 protein has a milder effect, acting as a positive
regulator of the KIF5/Miro/Trak2 trafficking complex;
however, it does not affect the ATPase activity of kinesins.
Taken together, the present data suggest both overlapping
and differential mechanisms and roles in the regulation of
mitochondrial dynamics and transport by Armc10/Armcx
family members.
Finally, we found that Armc10 overexpression causes a
slight increment in mitochondrial size under control condi-
tions. This increase may reflect a potential role of Armc10 in
mitochondrial fusion/fission. It is interesting to note that both
processes, trafficking and fission/fusion, are closely related
and are oftenmediated by the same proteins.3,31 Interestingly,
Armc10 overexpression prevents mitochondrial fragmenta-
tion and neuronal death produced by Ab oligomers. Armc10
mitochondrial fragmentation and fission induced by Ab is
considered to be a critical event in Ab-induced neurotoxicity,
which normally precedes neuronal death.32 Our results thus
support a protective role of Armc10 in Ab-induced toxicity. In
this context, it is also interesting to note that several members
of the Armc10/Armcx gene family are included in the
‘core proteome’ associated with Parkinson disease and that
at least the Armcx3 protein is a substrate of the Parkin/Pink1
ubiquitin/ligase complex involved in the pathogenesis of this
disease.33,34 Taken together, these findings suggest that
regulation of mitochondrial dynamics through the Armc10/
Armcx gene family may be involved in the pathogenesis of
neurodegenerative processes.
In conclusion, here we report that the Armc10 gene, the
phylogenetic ancestor of the Armcx gene cluster, has a
prominent role in the regulation ofmitochondrial dynamics and
trafficking in neurons. This regulation is probably mediated by
its interaction at the protein level with the KHC/Miro/Trak2
trafficking complex. It is interesting to note that the
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evolutionary appearance of the Armc10 gene in basal
chordates is coincidental with the genomic duplication of
mitochondrial dynamics-related genes, including mitofusins
and the Miro GTPases.35 This observation may suggest a
coordinated increase in the complexity of the molecular
machinery that regulates this process in vertebrates and,
specifically, in the most evolved mammals.
Taken together with our previous findings,11 our data
highlight that the function of the Armc10 ancestor gene in
mitochondrial trafficking has been conserved during the
evolution and development of the Armcx genomic cluster,
although some particular functions may have been acquired
during evolution (for example, mitochondrial aggregation). As
the Armcx gene cluster arose suddenly during the early
evolution of the most evolved mammals, the eutherians, our
data suggest an increased complexity in the molecular
mechanisms regulating mitochondrial dynamics and trafficking,
specifically in the nervous system of higher vertebrates.
Finally, and given the protection that the Armc10 exerts
against Ab-induced cell death and mitochondrial fragmenta-
tion, our data suggest that the novel Armc10/Armcx gene
family of mitochondrial proteins described here may
contribute to the pathophysiology of neurological diseases,
which often bear mutations or functional dysregulation of
proteins controlling mitochondrial dynamics in neurons.2,8
Materials and Methods
All procedures were performed in accordance with the guidelines approved by the
Spanish Ministry of Science and Technology and following the European
Community Council Directive 86/609 EEC.
Bioinformatics. Sequences for the genomic locus of Armc10 were
downloaded from the UCSC Genome Browser (assemblies were: GRCh37 for
human; GRCm38 for mouse; loxAfr3 for elephant; monDom5 for opossum;
ornAna1 for platypus; galGal4 for chicken; and xenTro3 for Xenopus tropicalis).
VISTA36 annotations for the human sequence were downloaded from the GRCh37
assembly on the Ensembl Genome Browser (ensembl.org/index.html). ENCODE
Project data were accessed via genome.ucsc.edu for H3K4me1 and H3K4me3
marks on all available cell lines. Domain structure was determined by NCBI,
Prosite, PPSearch, InterProScan and Wolfsort software. RNA-seq data (available
in the Sequence Read Archive (SRA)) was used to quantify Armc10 expression in
different tissues, according to the previosuly defined cRPKM expression values.37
S.D.s were calculated for tissues with several available expression values.
Plasmid vectors. The full sequence of Armc10 fully fused to myc epitope and
shRNAi sequences for this protein were obtained from Origene (MR204310 and
TG5187). For the generation of Armc10-GFP expression vectors, the Armc10
sequence was subcloned into the pEGFP-N3 vector (Clontech, Mountain View,
CA, USA) and the construct was sequenced with BigDye-Terminator v3.1 (Applied
Biosystems, Carlsbad, CA, USA). The sequence of the selected shRNAi-Armc10
was 50-TCATGATGTGGATGTGAAAGAGAAAGCTTTCAAGAGAAGCTTTCTCTT
TCACATCCACATCATGATTTTTTG-30; and the scrambled shRNAi-control was
50-TGACCACCCTGACCTACGGCGTGCAGTGCTCAAGAGGCACTGCACGCC
GTAGGTCAGGGTGGTCATTTTTTG-30. The expression vectors Miro2-myc,
KIF5C-myc and Trak2-myc were as previously described.26,38 Mitochondrial-
targeted DsRed (MitDsRed) was a gift from Antonio Zorzano (IRB Barcelona).
Animals. OF1 embryos and postnatal mice (Iffra Credo, Lyon, France) were used.
The mating day was considered embryonic day 0 (E0) and the day of birth, postnatal
day 0 (P0). The following developmental stages were studied for histology: E16, P5
and Adult. Animals were anaesthetised with 4% halothane before killing.
Histology. Embryos and postnatal mice from E16, P5 and Adult stages were
fixed in 4% paraformaldehyde. Brains were cryoprotected, frozen and cut into
50-mm-thick coronal sections. Immunohistochemistry was performed in free-
floating sections. Rabbit anti-Armc10 (1 : 250, Sigma-Aldrich, Madrid, Spain) was
used as primary antibody and immunodetected with a rabbit secondary
biotinylated antibody (Vector Laboratories Inc., Burlingame, CA, USA). After
streptavidin-peroxidase reaction (Amersham, Piscataway, NJ, USA), sections were
developed with DAB, dehydrated and coverslipped.
Cell culture and transfection. HEK293T cells were used for all the
experiments. Cells were cultured in DMEM medium supplemented with 10%
FBS, 2 mM glutamine, 120mg/ml penicillin and 200mg/ml streptomycin. Upon
confluence, cells were trypsinised (0.25% w/v) and plated at the desired density.
After 2 days, cells were transfected using Fugene6 (Roche Diagnostics, West
Sussex, UK), following the manufacturer’s instructions and using a 1 : 1 DNA ratio
when two constructs were transfected. For immunoprecipitation assays, an empty
vector was used to balance transfected DNA when required.
E16 mouse brains were dissected in PBS containing 0.6% glucose and the
hippocampi were dissected out. After trypsin (Invitrogen, Carlsbad, CA, USA) and
DNAse treatment (Roche Diagnostics), tissue pieces were dissociated and cells
were seeded onto 0.5 mg/ml poly-L-lysine (Sigma-Aldrich)-coated coverslips (for
immunocytochemistry) or 35-mm Fluorodish plates (World Precision Instruments
Inc) for live-imaging in neurobasal medium (Gibco, Grand Island, NY, USA)
containing 2 mM glutamax, 120mg/ml penicillin, 200mg/ml streptomycin and B27
supplement (Invitrogen). Cells were maintained at 37 1C in the presence of 5% CO2,
and were cultured for between 5–6 days. Neuron transfection was carried out at four
DIV using Lipofectamine 2000 (Invitrogen), following the manufacturer’s instructions
and using a 1 : 3 DNA ratio when transfection of two constructs was required. Cells
were processed 24–48 h after transfection.
For mitochondrial fragmentation analysis, hippocampal neurons were
treated for 20 h before fixation with oligomeric Ab or vehicle. The Ab1–42
peptide was purchased from Bachem (Bubendorf, Switzerland). Soluble
oligomers of Ab1–42 were prepared as described previously.39–41 Briefly, 60 ml
of 1 mM Ab1–42 in HFIP (1,1,1,3,3,3-Hexafluor-2-propanol) was lyophilised and
stored at  80 1C. A working solution of 100 mM Ab1–42 was prepared by
dissolving the lyophilised Ab1–42 in 12 ml DMSO plus 600 ml DMEM-F12 (phenol-
and glutamine-free), and directly added to the culture medium to a final
concentration of 2 mM. Control cultures were treated with the same volume of
DMSO/DMEM-F12 vehicle.
Immunocytochemistry. HEK293T cells or neurons were fixed in 4%
paraformaldehyde. After fixation, cells were permeabilised with Triton X-100 in
PBS and blocked with blocking buffer (10% fetal bovine serum (Roche
Diagnostics), 0.2 M glycine, 0.1% Triton X-100 and 0.05% deoxycholic acid in
PBS-2% gelatin) for 1 h at room temperature. To label the cells, the following
antibodies or dyes were used: rabbit anti-Armc10 (1 : 250, Sigma-Aldrich), rabbit
anti-GFP (1 : 500, Invitrogen) and mouse anti-myc (1 : 500, Santa Cruz
Biotechnology, Heidelberg, Germany) in blocking buffer for 2 h and with the
corresponding secondary antibodies labelled with fluorochromes (Alexafluor 546 or
488, Invitrogen). Nuclei were stained with the specific dye Hoechst-33342. All
samples were mounted on Mowiol.
Imaging and quantification of axonal transport of mitochondria.
Hippocampal neurons were seeded onto Poly-L-lysine-coated Fluorodish plates
(World Precision Instruments Inc), transfected with Armc10-GFP and MitDsRed
and filmed 24–48 h later using a Leica TCS SP2 confocal microscope
(Leica Microsystems) equipped with a  63 immersion oil objective. Axonal
mitochondria were registered with an additional digital zoom of  1.7.
Time-lapse series of image stacks composed of five images (512 512 px)
were taken every 6 s for 15 min. All 151 stacks obtained were processed with the
Leica Confocal Software. Further image processing, analysis and video
compilation (10 frames per second) and edition was carried out using the
ImageJ software (version 1.43K, NIH, Bethesda, MD, USA). Kymographs were
generated with MetaMorph Software (Molecular Devices – MDS Analytical
Technologies, Sunnyvale, CA, USA). In overexpression experiments, 17 axons
were registered and analysed for each condition, while in silencing experiments
12 axons per group were recorded. In all cases, a mitochondrion was considered
motile when it moved more than 0.5 mm during 1 min of recording. Distances and
speeds of retrograde and anterograde transport were measured separately from
the corresponding kymographs, as previously described,42 and no tracking-
plugging was used.
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Imaging and quantification of mitochondrial length. Visualisation
and capture were performed using a  100/1.4 oil immersion objective on a Nikon
Eclipse E1000 microscope with an attached Olympus DP72 digital camera.
Images were processed with the NIH ImageJ ‘Analyse Particles’ module
measuring the Feret’s diameter of thresholded mitochondria. The length and
number of mitochondria were measured in a 50-mm axonal section per neuron.
Results are expressed as average mitochondrial length per axonal section.
Isolation of brain mitochondria and cell fractionation. The brains
of Adult C57BL6/J mice were dissected, and mitochondria were purified as
described.43 Briefly, brains were extracted in ice-cold isolation buffer (sucrose
250 mM, Tris 10 mM, EDTA 1 mM, NaF 2 mM, pH7.6) and homogenized with a
Teflon potter. Homogenates were centrifuged at 1500 g for 5 min (4 1C).
The supernatant was then centrifuged at 12 500 g (4 1C). The pellet was
collected, and both centrifugations were repeated. To purify mitochondria, the final
pellet was resuspended in 400ml of isolation buffer, layered on top of a
discontinuous Ficoll gradient (10 and 7% fractions), and centrifuged at 100 000 g
for 1 h (4 1C). The following antibodies were used as purification controls:
anti-SDHA (1 : 20 000, Abcam, Cambridge, UK) and anti-TOM20 (1 : 1000, Santa
Cruz Biotechnology) as mitochondrial markers; anti-LDHa (1 : 500, Santa Cruz
Biotechnology) as cytosolic marker; anti-tubulin (1 : 1000, Sigma-Aldrich) as
cytoskelton marker; and anti-synaptophysin (1 : 20 000, Millipore, Schwalbach,
Germany) as synaptosome marker.
Propidium iodide staining. To quantify Ab-induced cell death, hippocam-
pal neurons were seeded in 24-well plates and transfected with Armc10-GFP or
GFP. Cultures were treated with Ab1–42 as described above. After 24 h, cells
were incubated for 1 h with propidium iodide (1.5mm/ml) and counterstained with
Hoechst 33342 (1mg/ml). Cells were than washed three times with PBS and fixed
for 20 min with 0.1 M PB containing 4% of paraformaldehyde. Fluorescent
micrographs were randomly taken from coverslips for each condition. The number
of dying neurons (PI and Hoechst double-labelled pyknotic nuclei) versus
the total number of cells (Hoechst-labelled nuclei) per field, were counted. Data
represent eight fields per condition and experiment (from two independent
experiments).
Protein cell extracts, WB and immunoprecipitation. HEK293T cells
were obtained and lysed in Laemmli Buffer (LB) at 98 1C for 5 min. Twenty
micrograms of protein for each sample were loaded and run in polyacrylamide gels
at 100 V. Transfer to nitrocellulose membranes was performed in 120 mM glycine,
125 mM Tris, 0.1% SDS and 20% methanol at 35 V o.n. Membranes were then
blocked in TBS containing 5% non-fat dry milk and incubated with the primary
antibodies anti-Armc10 (1 : 1000, Sigma-Aldrich), anti-GFP (1 : 1000, Invitrogen)
and anti-myc (1 : 2000, Santa Cruz Biotechnology). Anti-actin was used as a
loading control (1 : 1000, Chemicon, Temecula, CA, USA). Secondary antibodies
coupled to HRP were used in a 1 : 2500 dilution in TBS containing 5% non-fat dry
milk. Labelling was visualised with ECL plus (Amersham Pharmacia Biotech).
HEK293T cells were lysed using a buffer containing 50 mM Tris-HCl pH7.5,
150 mM NaCl, 1.5 mM MgCl2, 5 mM EDTA, 1% Triton-100, 10% glycerol, protease
inhibitor cocktail (Roche Diagnostics Gmbh), 1 mM NaF, 0.5 M sodium pyropho-
sphate and 200 mM orthovanadate. Five hundred micrograms of total protein per
sample were used for the immunoprecipitation assays. Homogenates were
incubated overnight with anti-GFP (1 : 500, Invitrogen) and anti-myc (1 : 500, Santa
Cruz Biotechnology) at 4 1C. All the assays were performed for 2 h at 4 1C using
protein G-Sepharose beads (Sigma-Aldrich). After incubation with protein
G-Sepharose, samples were washed five times in washing buffer (10 mM Tris-
HCl pH8, 500 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100 and 0.5% NP-
40). LB was added to the beads, and they were then boiled at 98 1C for 5 min.
Proteins were then analysed using SDS-PAGE and WB.
Adult brain extracts were obtained by homogenisation in lysis buffer (50 mM
Tris-HCl, 150 mM NaCl, 5 mM EGTA, 10% glycerol, 1% Triton X-100, protease
inhibitor cocktail (Roche Diagnostics Gmbh), 1 mM PMSF and 200 mM
orthovanadate). Ten milligrams were incubated with 1 mg of antibodies
anti-KHC (Chemicon), anti-Miro1 (Sigma), anti-Trak2 (Sigma) and anti-Armc10
(Proteintech, Chicago, IL, USA). Immunoprecipitation was performed using
Protein G Magnetic Beads (Invitrogen) following the manufacturer’s instructions.
After this procedure, the beads were washed three times with PBS, eluted in SDS
sample buffer for 5 min at 85 1C and subjected to WB with the corresponding
antibodies.
Statistical analysis. Statistical analyses of differences were conducted using
one-way ANOVA with Bonferroni post hoc comparisons to compare three or more
groups or with Student’s t-test when required. Statistical significance was fixed at
Po0.05; *Po0.05, **Po0.01 and ***Po0.001.
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